Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial

NACompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Apnea, Sleep
Interventions
DEVICE

CPAP

CPAP plus BSC group Participants in the CPAP plus BSC group will receive CPAP treatment plus the aforementioned BSC intervention. CPAP treatment (LOTUS AUTO; Curative Medical Technology Inc., Beijing, China) will be initiated using standard clinical practice at each center. Participants in both groups will be asked to continue their usual medical care during the trial.

DIETARY_SUPPLEMENT

BSC

BSC only group Participants in the BSC only group will receive advice regarding lifestyle modification, sleep hygiene, naps, exercise, caffeine, and diet, and avoiding alcohol consumption, but no specific weight loss program, diet, or salt restriction will be suggested.

Trial Locations (1)

2002333

Otolaryngological Institute of Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

OTHER

NCT02886156 - Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial | Biotech Hunter | Biotech Hunter